摘要:
A delivery member comprises a substrate and, provided thereon, an electro-deposition coating film containing inorganic powder. The inorganic powder may be selected from the group consisting of a ceramic powder, a metal powder, and a ceramic powder whose particle surfaces are coated with a metal.
摘要:
A delivery member comprises a substrate and, provided thereon, an electro-deposition coating film containing inorganic powder. The inorganic powder may be selected from the group consisting of a ceramic powder, a metal powder, and a ceramic powder whose particle surfaces are coated with a metal.
摘要:
The coating apparatus comprises a body part, a head part detachably installed to this body part, and a connecting ring connecting the body part with the head part. The body part is provided with a cascade that boosts and outputs electric power and a plurality of tubes and a passage in which at least one of the optical signal, air, and coating circulates. The head part is provided with the rotary atomization head, an electric power transmission line that transmits the electric power output from the cascade, and a passage. On the connecting face of the body part, at least part of the cascade projects, and third port of the passage is exposed. On the connecting face of the head part, the electric power transmission line is connected, and a cascade insertion part in which the projected part of the cascade is inserted is formed, and a fourth port connected to the third port.
摘要:
A copolymer or a pharmacologically acceptable salt thereof is provided, which contains, as constitutional units, (a) one or more structural units of formula (I): wherein m is an integer of from 3 to 100, Alk represents alkyline, and R1 and R2 are the same or different and each represents hydrogen or optionally substituted alkyl, and (b) one or more structural units of formula (II): wherein R3 represents hydroxyl, optionally substituted alkoxy, optionally substituted aryloxy, or a group represented by the formula —NR4R5, wherein R4 and R5 are the same or different and each represents hydrogen or optionally substituted alkyl. There is further provided a pharmaceutical composition comprising said copolymer, a protein modifier comprising said copolymer, a complex of said copolymer with a protein, and method of preventing or treating diseases using said complex, use of said complex in the manufacture of a medicament for preventing or treating diseases and methods for the synthesis of said copolymers and said complexes.
摘要翻译:提供了一种共聚物或其药学上可接受的盐,其包含作为结构单元的(a)一种或多种式(I)的结构单元:其中m是3至100的整数,Alk表示烷基, SUP> 1和R 2相同或不同,各自表示氢或任选取代的烷基,和(b)一种或多种式(II)的结构单元:其中R 3表示羟基,任选取代的烷氧基,任选取代的芳氧基或由式-NR 4 R 5表示的基团,其中R 4 R 5和R 5相同或不同,各自表示氢或任选取代的烷基。 还提供一种药物组合物,其包含所述共聚物,包含所述共聚物的蛋白质改性剂,所述共聚物与蛋白质的复合物,以及使用所述复合物预防或治疗疾病的方法,所述复合物在制备用于预防 或治疗用于合成所述共聚物和所述复合物的疾病和方法。
摘要:
The coating apparatus comprises a body part, a head part detachably installed to this body part, and a connecting ring connecting the body part with the head part. The body part is provided with a cascade that boosts and outputs electric power and a plurality of tubes and a passage in which at least one of the optical signal, air, and coating circulates. The head part is provided with the rotary atomization head, an electric power transmission line that transmits the electric power output from the cascade, and a passage. On the connecting face of the body part, at least part of the cascade projects, and third port of the passage is exposed. On the connecting face of the head part, the electric power transmission line is connected, and a cascade insertion part in which the projected part of the cascade is inserted is formed, and a fourth port connected to the third port.
摘要:
A method for printing designs, patterns, characters, letters, and other desired images on an object having a convex or raised surface, wherein the images to be transferred onto the object is first carried on a flexible image carrier, then this flexible image carrying medium is disposed in a mutually opposed relationship with the object to be printed at a predetermined space interval provided therebetween, thereafter the flexible image carrying medium is caused to expand or bulge out toward the raised surface of the object to be printed by a fluid pressure to act on the flexible medium from one side thereof opposite to that where the image is carried, while controlling a degree of expansion of the flexible image carrying medium is controlled by a restrictive frame for the flexible image carrying medium to attain an intimate contact between the flexible image carrying medium and the object to be printed over the entire surface thereof.
摘要:
In an electrostatic coating apparatus (1), an electrically conductive coating material is supplied through a coating material supplying path (11) to a coating gun (13) to which a high voltage is applied. The electrostatic coating apparatus (1) is provided with an insulating and separating valve (32) capable of electrically insulating and separating the coating material supplying path (11) into an application side in which the high voltage is applied and a non-application side. The insulating and separating valve (32) is provided with a female coupling member (32U) having a first connecting portion (54) and a male coupling member (32D) having a second connecting portion (64). A supplying hole (55) for supplying a cleaning fluid to the first connecting portion (54) and the second connecting portion (64) and a discharging hole (56) for discharging the cleaning fluid supplied to the first connecting portion and the second connecting portion are provided on one of the female coupling member (32U) disposed on the non-application side and the male coupling member (32D).
摘要:
A normal person (i.e. a control) and liver diseases such as drug induced liver injury, an asymptomatic hepatitis B carrier, an asymptomatic hepatitis C carrier, chronic hepatitis B, chronic hepatitis C, liver cancer, a nonalcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), and simple steatosis (SS) are identified by measuring the concentrations of γ-Glu-X (X represents an amino acid or an amine) peptides or the levels of AST or ALT in blood and carrying out, for example, a multiple logistic regression based on the measured value.
摘要:
A copolymer or a pharmacologically acceptable salt thereof is provided, which contains, as constitutional units, (a) one or more structural units of formula (I): wherein m is an integer of from 3 to 100, Alk represents alkyline, and R1 and R2 are the same or different and each represents hydrogen or optionally substituted alkyl, and (b) one or more structural units of formula (II): wherein R3 represents hydroxyl, optionally substituted alkoxy, optionally substituted aryloxy, or a group represented by the formula —NR4R5, wherein R4 and R5 are the same or different and each represents hydrogen or optionally substituted alkyl. There is further provided a pharmaceutical composition comprising said copolymer, a protein modifier comprising said copolymer, a complex of said copolymer with a protein, and method of preventing or treating diseases using said complex, use of said complex in the manufacture of a medicament for preventing or treating diseases and methods for the synthesis of said copolymers and said complexes.
摘要翻译:提供了一种共聚物或其药学上可接受的盐,其包含作为结构单元的(a)一种或多种式(I)的结构单元:其中m为3至100的整数,Alk表示烷基,R1和 R 2相同或不同,各自表示氢或任选取代的烷基,和(b)一种或多种式(II)的结构单元:其中R 3表示羟基,任选取代的烷氧基,任选取代的芳氧基或由式 -NR4R5,其中R4和R5相同或不同,并且各自表示氢或任选取代的烷基。 还提供一种药物组合物,其包含所述共聚物,包含所述共聚物的蛋白质改性剂,所述共聚物与蛋白质的复合物,以及使用所述复合物预防或治疗疾病的方法,所述复合物在制备用于预防 或治疗用于合成所述共聚物和所述复合物的疾病和方法。